31 October 2022

Immunotherapy against the most aggressive breast cancers

October is World Breast Cancer Awareness Month. Throughout this month of October we presented a series of short videos about the Breast Unit's clinical activities and its research projects. This is one of the last two videos we will showcase in this series.

Immunotherapy against the most agressive breast cancers

In this short video, Marcio Debiasi, oncologist at the Breast Unit of the Champalimaud Foundation, presents a study dubbed KeyPARTNER, which is being carried out in this Unit with support from industrial funders. The study’s aim is to optimize the use of chemotherapy together with immunotherapy for the treatment of so-called “triple negative” breast cancers, which are considered to be the most aggressive breast tumours.

Please wait...